These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 19594

  • 1. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
    Braestrup C.
    J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C, Scheel-Krüger J.
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.
    Ross SB, Kelder D.
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143
    [Abstract] [Full Text] [Related]

  • 4. Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
    Fuller RW, Snoddy HD.
    J Pharm Pharmacol; 1979 Mar; 31(3):183-4. PubMed ID: 34697
    [No Abstract] [Full Text] [Related]

  • 5. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [Abstract] [Full Text] [Related]

  • 6. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 7. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 18; 240(1):241-50. PubMed ID: 3100770
    [Abstract] [Full Text] [Related]

  • 8. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
    Segal DS, Kuczenski R, Okuda C.
    Pharmacol Biochem Behav; 1992 Jul 18; 42(3):421-9. PubMed ID: 1409775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 18; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 12. Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats.
    Glick SD, Carlson JN, Baird JL, Maisonneuve IM, Bullock AE.
    Brain Res; 1988 Nov 08; 473(1):161-4. PubMed ID: 3208119
    [Abstract] [Full Text] [Related]

  • 13. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.
    Butcher SP, Liptrot J, Aburthnott GW.
    Neurosci Lett; 1991 Jan 28; 122(2):245-8. PubMed ID: 1902922
    [Abstract] [Full Text] [Related]

  • 14. A comparison of circling models for the detection of antiparkinson activity.
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jan 28; 41(1):57-64. PubMed ID: 1091939
    [Abstract] [Full Text] [Related]

  • 15. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ.
    Br J Pharmacol; 1994 Dec 28; 113(4):1391-9. PubMed ID: 7889297
    [Abstract] [Full Text] [Related]

  • 16. Antagonism by methylphenidate of the stereotyped behaviour produced by (+)-amphetamine in reserpinized rats.
    Ross SB.
    J Pharm Pharmacol; 1978 Apr 28; 30(4):253-4. PubMed ID: 24718
    [No Abstract] [Full Text] [Related]

  • 17. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 28; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 18. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
    Breese GR, Cooper BR, Hollister AS.
    Psychopharmacologia; 1975 Oct 14; 44(1):5-10. PubMed ID: 128026
    [Abstract] [Full Text] [Related]

  • 19. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct 14; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

  • 20. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr 14; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.